[Special Stock] Alzheimer Early Diagnosis Related Stocks... PeopleBio Hits Upper Limit↑
PeopleBio, a company possessing technology related to the early diagnosis of Alzheimer's disease, has hit the upper price limit.
As of 2:05 PM on the 29th, PeopleBio is trading on the KOSDAQ market at 3,750 KRW, up 865 KRW (29.98%) from the previous day.
Founded in September 2002, PeopleBio is a company primarily engaged in pharmaceutical development using biotechnology, food ingredient development, chemical substance development and supply, and consulting.
The company's main product includes a blood test product that can be used for the early diagnosis of Alzheimer's disease, one of the representative degenerative brain diseases.
Hot Picks Today
![Received a Galaxy Watch as a Chuseok Gift, but Use Prohibited for Under 22s and Pregnant Women [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/93/2026092909233143401_1790641411.png)
Received a Galaxy Watch as a Chuseok Gift, but Use Prohibited for Under 22s and Pregnant Women [Why&Next]
- Thought They Were Working as Usual...The Quiet Trend of Double Lives: U.S. Office Workers "Exploring Alternative Career Paths"
- DPK: "Special Counsel on Fabricated Indictments to Be Addressed in Caucus... Agenda Yet to Be Finalized"
- "One in Three Unsuitable for Marriage": 72-Year-Old Professor's Diagnosis Sparks Fierce Debate Among Chinese Netizens
Currently, the Alzheimer's blood test under the AlzOn brand is being conducted at 120 medical institutions nationwide, including advanced general hospitals, health screening centers, and clinics.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Failed Even With Net Assets of 400 Million Won?"... Six Criteria That Define 'The Real Middle Class' [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026092809144741876_1790554486.jpg)
